USNU (Elite Health Systems) Debt-to-Equity : 0.02 (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Elite Health Systems Debt-to-Equity?

Elite Health Systems's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $0.03 Mil. Elite Health Systems's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $0.04 Mil. Elite Health Systems's Total Stockholders Equity for the quarter that ended in Dec. 2024 was $4.18 Mil. Elite Health Systems's debt to equity for the quarter that ended in Dec. 2024 was 0.02.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Elite Health Systems's Debt-to-Equity or its related term are showing as below:

USNU' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02 Med: 0.25 Max: 1.62
Current: 0.02

During the past 13 years, the highest Debt-to-Equity Ratio of Elite Health Systems was 1.62. The lowest was 0.02. And the median was 0.25.

USNU's Debt-to-Equity is ranked better than
94.84% of 562 companies
in the Healthcare Providers & Services industry
Industry Median: 0.44 vs USNU: 0.02

Elite Health Systems Debt-to-Equity Historical Data

The historical data trend for Elite Health Systems's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elite Health Systems Debt-to-Equity Chart

Elite Health Systems Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Equity

Get a 7-Day Free Trial

0.05

0.03

0.02

0.13

0.02

Elite Health Systems Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Equity	Get a 7-Day Free Trial															0.13	0.24	0.04	0.02	0.02

Competitive Comparison of Elite Health Systems's Debt-to-Equity

For the Medical Care Facilities subindustry, Elite Health Systems's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elite Health Systems's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Elite Health Systems's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Elite Health Systems's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Elite Health Systems Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Elite Health Systems's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.034	+	0.038)	/	4.178
	=	0.02

Elite Health Systems's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.034	+	0.038)	/	4.178
	=	0.02

Elite Health Systems (OTCPK:USNU) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Elite Health Systems Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Elite Health Systems's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Elite Health Systems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Elite Health Systems Inc (OTCPK:USNU) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

1131 W 6th Street, Ontario, CA, USA, 91672

Website

http://www.usneuro.com

US Neurosurgical Holding Inc operates as a holding company in the United States. It is a medical services company that partners with hospitals and physicians to operate facilities utilizing artistic and inventive technologies in medical treatment and diagnosis. It is engaged in providing medical treatment and diagnosis services that include stereotactic radiosurgery centers, utilizing gamma knife technology, and holds interests in radiological treatment facilities. The company is focusing on establishing cancer centers using intensity-modulated radiation therapy. Its gamma knife is a stereotactic radiosurgical device used to treat brain tumors and other malformations of the brain without invasive surgery.

Executives

Lawrence William St	director	23 ASHLAND STREET, NEWBURYPORT MA 01950-1905
William F. Leimkuhler	director	43 SALEM STRAITS RD, DARIEN CT 06820
Merriman Charles H Iii	director
Alan Gold	director, 10 percent owner, officer: President & Chairman	2400 RESEARCH BLVD, SUITE 325, ROCKVILLE MD 20850
Stanley S Shuman	10 percent owner	C/O RIPPLEWOOD HOLDINGS LLC, ONE ROCKERFELLER PLAZA, NEW YORK NY 10020
Allen & Co Inc	10 percent owner	711 FIFTH AVENUE, NEW YORK NY 10022